Anzeige
Meldung des Tages: Antimon-Preis verdreifacht – startet jetzt der nächste Rohstoff-Run?
Werbung
Attraktive Knock-Outs auf Medtronic plc
Typ Hebel Bid / Ask WKN
Call
4,8 1,69 € / 1,76 €
SN1TX7
Typ Hebel Bid / Ask WKN
Put
5,7 1,42 € / 1,49 €
SF96P3
Den Basisprospekt sowie endgültige Bedingungen und Basisinformationsblätter erhalten Sie bei Klick auf das Dokument-Icon. Beachten Sie auch die weiteren Hinweise zu dieser Werbung. Der Emittent ist berechtigt, Wertpapiere mit open end-Laufzeit zu kündigen.
Alle Knock-Outs auf Medtronic plc

Medtronic Aktie News

Aktie
WKN:  A14M2J ISIN:  IE00BTN1Y115 US-Symbol:  MDT Branche:  Gesundheitswesen: Ausstattung u. Produkte Land:  Irland
83,18 €
+0,28 €
+0,34%
13:26:15 Uhr
Depot/Watchlist
Marktkapitalisierung *
104,95 Mrd. €
Streubesitz
11,23%
KGV
23,41
Dividende
2,83 $
Dividendenrendite
3,47%
Nachhaltigkeits-Score
40 %
Index-Zuordnung
S&P 500
Weiter aufwärts? Long handeln - Jetzt mit Hebel 13,16: MM79KU
Werbung

Medtronic News

18.11.25 - wallstreetONLINE Redaktion
Ihre wichtigsten Termine: Heute im Fokus: Bertelsmann, Medtronic, Biontech, Rheinmetall & Imperial Brands
Gut geplant in den Tag. Mit dem wO-​Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine ...
05.11.25 - PR Newswire
Medtronic to announce financial results for its second quarter of fiscal year 2026
Medtronic to announce financial results for its second quarter of fiscal year 2026 PR Newswire
28.10.25 - PR Newswire
U.S. Centers for Medicare & Medicaid Services finalizes National Coverage Determination for the Medtronic Symplicity Spyral™ renal denervation (RDN) system
U.S. Centers for Medicare & Medicaid Services finalizes National Coverage Determination for the Medtronic Symplicity Spyral™ renal denervation (RDN) system PR Newswire
26.10.25 - PR Newswire
Three-year SPYRAL HTN-ON MED results show sustained, 18 mmHg office-based blood pressure reductions
Three-​year SPYRAL HTN-ON MED results show sustained, 18 mmHg office-​based blood pressure reductions PR Newswire
09.10.25 - PR Newswire
Medtronic BrainSense™ Adaptive Deep Brain Stimulation named a 2025 TIME Best Inventions
Medtronic BrainSense™ Adaptive Deep Brain Stimulation named a 2025 TIME Best Inventions PR Newswire
08.10.25 - PR Newswire
Medtronic initiates U.S. IDE clinical study evaluating Hugo™ robotic-assisted surgery system for gynecological procedures
Medtronic initiates U.S. IDE clinical study evaluating Hugo™ robotic-​assisted surgery system for gynecological procedures PR Newswire
29.09.25 - PR Newswire
Medtronic Announces Closing of Public Offering of €1.5 Billion of Senior Notes
Medtronic Announces Closing of Public Offering of €1.5 Billion of Senior Notes PR Newswire
19.09.25 - PR Newswire
Medtronic secures FDA approval for the Altaviva™ device, a simple experience for treating urge urinary incontinence
Medtronic secures FDA approval for the Altaviva™ device, a simple experience for treating urge urinary incontinence PR Newswire
15.09.25 - PR Newswire
Medtronic Announces Pricing of €1.5 Billion of Senior Notes
Medtronic Announces Pricing of €1.5 Billion of Senior Notes PR Newswire
15.09.25 - PR Newswire
Medtronic initiates global pivotal study of cardiac pacing in a new patient population
Medtronic initiates global pivotal study of cardiac pacing in a new patient population PR Newswire
04.09.25 - PR Newswire
Study of Medtronic Hugo™ robotic-assisted surgery system in hernia repair meets safety and effectiveness endpoints
Study of Medtronic Hugo™ robotic-​assisted surgery system in hernia repair meets safety and effectiveness endpoints PR Newswire
02.09.25 - PR Newswire
FDA Clears MiniMed™ 780G System to Enable Integration with the Instinct Sensor, Made by Abbott, and Approves Use in Type 2 Diabetes
FDA Clears MiniMed™ 780G System to Enable Integration with the Instinct Sensor, Made by Abbott, and Approves Use in Type 2 Diabetes PR Newswire
29.08.25 - PR Newswire
Medtronic executives to speak at upcoming investor conferences
Medtronic executives to speak at upcoming investor conferences PR Newswire
27.08.25 - ARIVA.DE Redaktion
"Keine gute Idee, noch Techs zu kaufen": Stattdessen sollten Anleger diese 8 Aktien jetzt genauer prüfen!
Technologieaktien haben in den vergangenen Jahren Rekordniveaus erreicht. Anleger setzen weiter auf das Wachstum von Chipproduzenten wie Nvidia und Softwarekonzernen wie ...
19.08.25 - PR Newswire
Medtronic announces Board appointments and shareholder value creation initiatives to advance strategic priorities
Medtronic announces Board appointments and shareholder value creation initiatives to advance strategic priorities PR Newswire
19.08.25 - PR Newswire
Medtronic reports first quarter fiscal 2026 financial results
Medtronic reports first quarter fiscal 2026 financial results PR Newswire
19.08.25 - wallstreetONLINE Redaktion
Ihre wichtigsten Termine: Home Depot, DocMorris, Medtronic, Stratec, Baywa und Alcon legen Zahlen vor!
Gut geplant in den Tag. Mit dem wO-​Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine ...
14.08.25 - PR Newswire
Medtronic announces cash dividend for second quarter of fiscal year 2026
Medtronic announces cash dividend for second quarter of fiscal year 2026 PR Newswire
05.08.25 - PR Newswire
Medtronic to announce financial results for its first quarter of fiscal year 2026
Medtronic to announce financial results for its first quarter of fiscal year 2026 PR Newswire
21.07.25 - PR Newswire
Medtronic secures CE Mark for MiniMed™ 780G System for insulin-requiring people with diabetes including expanded indications in children as young as two, during pregnancy, and for type 2 diabetes
Medtronic secures CE Mark for MiniMed™ 780G System for insulin-​requiring people with diabetes including expanded indications in children as young as two, during pregnancy, and ...

Newssuche

Videos

newspaper
18.02.26 -1,52%
Technical Trading: Chance mit 82 Prozent Treffern
Rohöl Long Typ: Turbo Open End WKN: VH65XQ Hebel:6 Laufzeit: OpenEnd Einstieg: Market ... Mehr »
Anzeige

Aktie im Fokus

Antimon-Preis verdreifacht
Antimony Resources Corp
0,487 €
+2,85%
Antimony Resources Corp Chart
Startet jetzt der nächste Rohstoff-Run?
Mehr zur Aktie »